AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

138.500

+3.8802.88%

Volume:4.16M

Turnover:636.89M

Market Cap:67.19B

PE:34.13

High:138.800

Open:135.990

Low:134.900

Close:134.620

52wk High:269.118

52wk Low:133.350

Shares:485.15M

Float Shares:483.95M

Volume Ratio:3.47

T/O Rate:0.86%

Dividend:4.15

Dividend Rate:2.99%

EPS(TTM):4.058

EPS(LYR):8.760

ROE:6.66%

ROA:6.58%

PB:2.54

PE(LYR):15.81

Loading ...

Overview Company News Filings

Should you buy CSL and Pro Medicus shares today?

Here are the latest growth forecasts for the CSL share price

3 ASX stocks brokers say could double in the next year

CSL (ASX:CSL) Valuation Check After A$1.5b Kankakee Expansion Commitment

Simply Wall St.

CitiFirst CSL SFIs Dividend Final Amount-CTW

Did CSL's US$1.5 Billion US Plasma Build-Out Just Shift CSL's (ASX:CSL) Investment Narrative?

Simply Wall St.

What on earth's going on with the CSL share price?

CSL Finance Board to Consider Debenture Issue

MT Newswires Live

CSL Shares Fall as It Enters Long-Term Agreement With Pan American Health Organization for Influenza Vaccines

MT Newswires Live

BRIEF-Csl Seqirus Signs Agreement With Pan American Health Organization

CSL Ltd - CSL Seqirus Will Supply Its Differentiated Influenza Vaccine Portfolio and, With Long-Term Partner Sinergium Biotech

THOMSON REUTERS

Australian Shares Rebound; Telix Says First Part of Phase Three Study Confirms Safety Profile of Drug Candidate

MT Newswires Live

Top 10 ASX 200 Stocks to Consider Following Market Downturn

ASX Midday Sector Update: Health Care Stocks Rise, Energy Struggles

MT Newswires Live

CSL Shares Rise After Manufacturing Facility Expansion Announcement

MT Newswires Live

CSL to invest USD 1.5 billion to expand Kankakee, Illinois plasma therapy plant

BRIEF-CSL Announces Expansion Of Illinois Plasma Therapy Manufacturing Facility

CSL: Expansion Will Create at Least 300 New Pharmaceutical Roles

THOMSON REUTERS

CitiFirst CSL SFIs Dividend Estimated Amount-CTW

CSL Seqirus Wins Canada Pandemic Flu Vaccine Contract

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CSL.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":138.5,"timestamp":1773983520000,"preClose":134.62,"halted":0,"volume":4158551,"delay":0,"changeRate":0.02882186896449261,"nameEN":"CSL LIMITED","floatShares":483950454,"shares":485151394,"eps":4.057864546358085,"marketStatus":"Market Closed","change":3.88,"latestTime":"03-20 16:12:00 AEDT","open":135.99,"high":138.8,"low":134.9,"amount":636891688,"amplitude":0.02897,"askPrice":138.6,"askSize":200,"bidPrice":138.1,"bidSize":210,"shortable":3,"etf":0,"ttmEps":4.057864546358085,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1774220400000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":134.62,"dividendRate":0.029914,"openAndCloseTimeList":[[1773961200000,1773982800000]],"volumeRatio":3.4717679477714842,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":134.62,"auctionPrice":138.49,"auctionVolume":2223596,"auction":3,"marketStatus":"盘后竞价","timestamp":1773983424685}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483950454,"roa":"6.58%","roe":"6.66%","lyrEps":8.76047,"volumeRatio":3.4717679477714842,"shares":485151394,"dividePrice":4.145961,"high":138.8,"amplitude":0.02897,"preClose":134.62,"low":134.9,"week52Low":133.35,"pbRate":"2.54","psRate":"3.07","week52High":269.118,"institutionHeld":0,"latestPrice":138.5,"committee":0.02439,"eps":4.057864546358085,"divideRate":0.029935,"volume":4158551,"delay":0,"ttmEps":4.057864546358085,"open":135.99,"prevYearClose":170.408,"prevWeekClose":141.03,"prevMonthClose":144.854,"prevQuarterClose":170.408,"fiveDayClose":141.03,"twentyDayClose":151.279,"sixtyDayClose":174.02,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":4,"dividendGrowthRate":0.11620984529927163,"fiveYearAvgDividendRate":0.013228653048611719},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"},{"date":"2025-08-19","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755561600000,"name":null,"time":"","dateTimestamp":1755525600000,"actualEps":null},{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620951954","title":"Should you buy CSL and Pro Medicus shares today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620951954","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620951954?lang=en_us&edition=fundamental","pubTime":"2026-03-17 03:00","pubTimestamp":1773687600,"startTime":"0","endTime":"0","summary":"Healthcare shares have been among the biggest fallers on the ASX over the past year. Two of the sector's biggest names — CSL Ltd  and Pro Medicus Ltd  — have both seen their share prices slump heavily. They declined roughly 40% or more over the past 12 months. When CSL and Pro Medicus shares fall this far, investors often start asking the same question: is this a buying opportunity, or a sign that more downside is ahead?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/17/should-you-buy-csl-and-pro-medicus-shares-today/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/17/should-you-buy-csl-and-pro-medicus-shares-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7067","CSL","BK7501","BK7094","LU1169590202.USD","SG9999004303.SGD","BK7511","LU1169589451.USD","PME.AU","BK7508","SGXZ23171101.USD","CSL.AU","LU0728928796.USD","BK4086"],"gpt_icon":0},{"id":"2619485792","title":"Here are the latest growth forecasts for the CSL share price","url":"https://stock-news.laohu8.com/highlight/detail?id=2619485792","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619485792?lang=en_us&edition=fundamental","pubTime":"2026-03-16 06:00","pubTimestamp":1773612000,"startTime":"0","endTime":"0","summary":"The CSL Ltd (ASX: CSL) share price has been through a tough time over the past two years. As the chart below shows, it's down more than 50% since August 2024.  As a result of this decline, it has fall","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/16/here-are-the-latest-growth-forecasts-for-the-csl-share-price-4/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/16/here-are-the-latest-growth-forecasts-for-the-csl-share-price-4/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4588","SG9999004303.SGD","MQG.AU","BK4585","BK7067","BK7041","BK4086","LU1169590202.USD","LU1863844749.USD","BK4534","BK7508","BK7153","CSL","LU0728928796.USD","WES.AU","LU1829250122.USD","BK7046","BK7511","UBS","BK4118","LU3187612489.SGD","BK7501","LU1169589451.USD","LU1863844665.USD","IE0034235071.USD","CSL.AU","SGXZ23171101.USD"],"gpt_icon":0},{"id":"2619483450","title":"3 ASX stocks brokers say could double in the next year","url":"https://stock-news.laohu8.com/highlight/detail?id=2619483450","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619483450?lang=en_us&edition=fundamental","pubTime":"2026-03-16 04:30","pubTimestamp":1773606600,"startTime":"0","endTime":"0","summary":"With March bringing significant volatility for ASX stocks, there is plenty of opportunity for value investors. Unsurprisingly, much of the opportunity lies with ASX healthcare and technology stocks th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/16/3-asx-stocks-brokers-say-could-double-in-the-next-year/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/16/3-asx-stocks-brokers-say-could-double-in-the-next-year/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7501","XJO.AU","CSL.AU","BK7511","BK7508","BK7094","PME.AU","BK7503","WTC.AU","BK7067","BK7016"],"gpt_icon":0},{"id":"2619144761","title":"CSL (ASX:CSL) Valuation Check After A$1.5b Kankakee Expansion Commitment","url":"https://stock-news.laohu8.com/highlight/detail?id=2619144761","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619144761?lang=en_us&edition=fundamental","pubTime":"2026-03-14 08:41","pubTimestamp":1773448890,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) has just committed A$1.5b to expand its Kankakee, Illinois manufacturing site, using its Horizon 2 process to lift plasma therapy output and add hundreds of U.S. jobs.\nSee our latest analysis for CSL.\nDespite committing fresh capital to grow its U.S. footprint, CSL’s share price has faced pressure, with a 30 day share price return decline of 13.71% and a 1 year total shareholder return loss of 42.19%, suggesting recent news is being weighed against longer term concerns.\nIf CSL’s...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-valuation-check-after-a15b-kankakee-expansion-com","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-valuation-check-after-a15b-kankakee-expansion-com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CSL","CSL.AU","BK7501","LU0728928796.USD","SG9999004303.SGD","SGXZ23171101.USD","BK4086","BK7511","LU1169589451.USD","LU1169590202.USD","BK7508","BK7067"],"gpt_icon":0},{"id":"2619567761","title":"CitiFirst CSL SFIs Dividend Final Amount-CTW","url":"https://stock-news.laohu8.com/highlight/detail?id=2619567761","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619567761?lang=en_us&edition=fundamental","pubTime":"2026-03-13 08:58","pubTimestamp":1773363498,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260313:nASX4y5CS9","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nASX7KzSnD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7501","BK7067","BK7511","BK7508"],"gpt_icon":0},{"id":"2619540831","title":"Did CSL's US$1.5 Billion US Plasma Build-Out Just Shift CSL's (ASX:CSL) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2619540831","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619540831?lang=en_us&edition=fundamental","pubTime":"2026-03-13 05:31","pubTimestamp":1773351079,"startTime":"0","endTime":"0","summary":"CSL has recently broken ground on a US$1.50 billion expansion of its Kankakee, Illinois plasma-therapy manufacturing facility, adding at least 300 new pharmaceutical jobs and incorporating its patented Horizon 2 process to increase immunoglobulin and albumin production capacity by 2031.\nThis large-scale build-out not only deepens CSL’s U.S. manufacturing footprint but also advances its goal of end-to-end plasma processing within the United States, which may be important for supply resilience...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/did-csls-us15-billion-us-plasma-build-out-just-shift-csls-as","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/did-csls-us15-billion-us-plasma-build-out-just-shift-csls-as","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","CSL","BGSX","BK7501","LU1169590202.USD","SG9999004303.SGD","BK7511","LU1169589451.USD","SGXZ23171101.USD","BK7508","CSL.AU","LU0728928796.USD","BK4086"],"gpt_icon":0},{"id":"2619808156","title":"What on earth's going on with the CSL share price?","url":"https://stock-news.laohu8.com/highlight/detail?id=2619808156","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619808156?lang=en_us&edition=fundamental","pubTime":"2026-03-12 05:45","pubTimestamp":1773265500,"startTime":"0","endTime":"0","summary":"It has been a rough year for shareholders of CSL Ltd . Earlier this week, the biotech giant's share price hit a multi-year low of $140.93 during a broader market selloff. Even after a modest rebound, the stock is still trading at $142.58, which leaves it down roughly 43% over the past 12 months. For a company long considered one of the highest-quality businesses on the ASX, that sort of decline naturally raises questions. What exactly has gone wrong, and does the weakness create an opportunity for investors?This is where I think the debate becomes interesting. According to analysts at Morgans, CSL's first-half result was \"softer and less clean than expected,\" with profit declining and impairments wei","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/12/what-on-earths-going-on-with-the-csl-share-price/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/12/what-on-earths-going-on-with-the-csl-share-price/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7067","BK7511","LU0728928796.USD","BK7501","CSL","BK7508","LU1169590202.USD","BK4086","LU1169589451.USD","CSL.AU","SG9999004303.SGD","SGXZ23171101.USD"],"gpt_icon":0},{"id":"2618947105","title":"CSL Finance Board to Consider Debenture Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2618947105","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618947105?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:50","pubTimestamp":1773233409,"startTime":"0","endTime":"0","summary":"CSL Finance (NSE:CSLFINANCE, BOM:530067) said its board will meet on March 18 to consider fund raising through issue of non-convertible debentures on a private placement basis, according to a Wednesday filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0728928796.USD","LU1169589451.USD","LU1169590202.USD","CSL","BK7067","SG9999004303.SGD","BK4086","BK7508","SGXZ23171101.USD","BK7501","BK7511","CSL.AU"],"gpt_icon":0},{"id":"2618956579","title":"CSL Shares Fall as It Enters Long-Term Agreement With Pan American Health Organization for Influenza Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2618956579","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618956579?lang=en_us&edition=fundamental","pubTime":"2026-03-11 09:15","pubTimestamp":1773191753,"startTime":"0","endTime":"0","summary":"CSL  shares were down nearly 2% in recent trading on Wednesday after it said in a late Tuesday statement that CSL Seqirus entered into a long-term agreement with the Pan American Health Organization Regional Revolving Fund to advance influenza protection in the Latin America region.CSL Seqirus will supply its differentiated portfolio of influenza vaccines, working with its long-term production partner, the Argentina-based Sinergium Biotech, to localize vaccine filling and distribution.CSL Seqirus and Sinergium will invest $10 million to enable the transfer of technology capability, which will add to the recent $25 million investment by Sinergium Biotech to increase local filling capacity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL.AU","BK7067","LU1169589451.USD","BK4117","SG9999004303.SGD","BK4107","SGXZ23171101.USD","BK4086","LU1169590202.USD","BK7501","BK7511","CSL","BK7508","AFG","LU0728928796.USD"],"gpt_icon":1},{"id":"2618050951","title":"BRIEF-Csl Seqirus Signs Agreement With Pan American Health Organization","url":"https://stock-news.laohu8.com/highlight/detail?id=2618050951","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618050951?lang=en_us&edition=fundamental","pubTime":"2026-03-10 23:04","pubTimestamp":1773155040,"startTime":"0","endTime":"0","summary":"BRIEF-Csl Seqirus Signs Agreement With Pan American Health OrganizationMarch 10  - CSL Ltd CSL.AX:CSL SEQIRUS SIGNS LONG-TERM AGREEMENT WITH PAN AMERICAN HEALTH ORGANIZATIONCSL SEQIRUS WILL SUPPLY ITS DIFFERENTIATED INFLUENZA VACCINE PORTFOLIO AND, WITH LONG-TERM PARTNER SINERGIUM BIOTECHFurther company coverage: CSL.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY1FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7501","BK7511","BK7508","BK7067"],"gpt_icon":0},{"id":"2618951729","title":"CSL Ltd - CSL Seqirus Will Supply Its Differentiated Influenza Vaccine Portfolio and, With Long-Term Partner Sinergium Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2618951729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618951729?lang=en_us&edition=fundamental","pubTime":"2026-03-10 23:00","pubTimestamp":1773154827,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY1FH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7511","BK7501","BK7508","CSL.AU"],"gpt_icon":0},{"id":"2618198572","title":"Australian Shares Rebound; Telix Says First Part of Phase Three Study Confirms Safety Profile of Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2618198572","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618198572?lang=en_us&edition=fundamental","pubTime":"2026-03-10 13:50","pubTimestamp":1773121856,"startTime":"0","endTime":"0","summary":"Australian shares rebounded at Tuesday's close as market sentiment improved over US President Donald Trump's comments on the conflict in the Middle East.The S&P/ASX 200 Index regained 1.09%, or 93.60 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL.AU","XKO.AU","BK7501","EBIT","BK7511","TLX.AU","XAO.AU","ORI.AU","BK7017","BK7508","XJO.AU","BK7067"],"gpt_icon":0},{"id":"1157525084","title":"Top 10 ASX 200 Stocks to Consider Following Market Downturn","url":"https://stock-news.laohu8.com/highlight/detail?id=1157525084","media":"Trading Random","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157525084?lang=en_us&edition=fundamental","pubTime":"2026-03-10 10:14","pubTimestamp":1773108866,"startTime":"0","endTime":"0","summary":"The ASX 200 index experienced a significant decline on Monday, driven by a sharp increase in oil prices amid escalating tensions in the Middle East.While such market corrections can be concerning in...","market":null,"thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Top 10 ASX 200 Stocks to Consider Following Market Downturn","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7155","BK7511","GMG.AU","BK4167","BK4504","TNE.AU","CSL.AU","COH.AU","XRO.AU","BK7094","LU0170899867.USD","WTC.AU","BK4082","BK7007","BK7078","BK7503","BK4077","IE00B5TLWC47.USD","RMD.AU","REA.AU","BK7067","BK7016","BK7508","LU2177674079.SGD","BK7002","PME.AU","BK7510","BK4567","BK7501","BK7099","LNW.AU","LU2008162690.USD","BK4548","BK4588","BK4585"],"gpt_icon":0},{"id":"2618960455","title":"ASX Midday Sector Update: Health Care Stocks Rise, Energy Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2618960455","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618960455?lang=en_us&edition=fundamental","pubTime":"2026-03-10 10:08","pubTimestamp":1773108507,"startTime":"0","endTime":"0","summary":"Health care stocks advanced 2% at midday Tuesday.CSL  shares rose more than 2% in recent trade after the biotechnology company disclosed the $1.5 billion expansion of its Illinois plasma therapy manufacturing facility on Monday.Meanwhile, the energy sector struggled, shedding 4% amid geopolitical tensions in the Middle East.Woodside Energy Group  shares fell past 5% in recent trade, while Santos  shares fell 4%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","BK7507","BK4588","BK7508","BK7067","BK4585","STO.AU","LABU","XLV","XBI","BK7142","WDS.AU","BK7501","CSL.AU","BK7511"],"gpt_icon":0},{"id":"2618609190","title":"CSL Shares Rise After Manufacturing Facility Expansion Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2618609190","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618609190?lang=en_us&edition=fundamental","pubTime":"2026-03-10 09:18","pubTimestamp":1773105504,"startTime":"0","endTime":"0","summary":"CSL  shares rose nearly 3% in morning trade on Tuesday after the biotechnology company disclosed the $1.5 billion expansion of its Illinois plasma therapy manufacturing facility on Monday.The expansion, set to be operational by 2031, will feature the company's Horizon 2 technology, the statement said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","CSL","BK7501","LU1169590202.USD","SG9999004303.SGD","BK7511","LU1169589451.USD","SGXZ23171101.USD","BK7508","CSL.AU","LU0728928796.USD","BK4086"],"gpt_icon":0},{"id":"2618627430","title":"CSL to invest USD 1.5 billion to expand Kankakee, Illinois plasma therapy plant","url":"https://stock-news.laohu8.com/highlight/detail?id=2618627430","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618627430?lang=en_us&edition=fundamental","pubTime":"2026-03-09 23:01","pubTimestamp":1773068486,"startTime":"0","endTime":"0","summary":"CSL broke ground on an expansion of its plasma-therapy manufacturing facility in Kankakee, Illinois. The project includes a USD 1.5 billion investment to increase production of plasma-derived therapies and albumin. CSL said the expansion is expected to be operational by 2031 and will incorporate its Horizon 2 manufacturing process to increase immunoglobulin yield from the same amount of plasma. The company expects the expansion to create at least 300 new pharmaceutical roles and about 800 construction-related jobs. CSL said it has invested more than USD 3 billion in its U.S. operations since 2018.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL6mhmJt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7508","CSL.AU","BK7501"],"gpt_icon":0},{"id":"2618442627","title":"BRIEF-CSL Announces Expansion Of Illinois Plasma Therapy Manufacturing Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2618442627","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618442627?lang=en_us&edition=fundamental","pubTime":"2026-03-09 23:00","pubTimestamp":1773068403,"startTime":"0","endTime":"0","summary":"BRIEF-CSL Announces Expansion Of Illinois Plasma Therapy Manufacturing FacilityMarch 9  - CSL Ltd CSL.AX:CSL: ANNOUNCES EXPANSION OF ILLINOIS PLASMA THERAPY MANUFACTURING FACILITYCSL: KANKAKEE ILLINOIS FACILITY EXPANSION, EXPECTED TO BE OPERATIONAL BY 2031CSL: EXPANSION WILL CREATE AT LEAST 300 NEW PHARMACEUTICAL ROLESFurther company coverage: CSL.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nP8N3T600Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7511","BK7501","BK7067","CSL.AU"],"gpt_icon":0},{"id":"2618627621","title":"CSL: Expansion Will Create at Least 300 New Pharmaceutical Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2618627621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618627621?lang=en_us&edition=fundamental","pubTime":"2026-03-09 23:00","pubTimestamp":1773068400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nP8N3T600Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","BK7511","CSL.AU","BK7067"],"gpt_icon":0},{"id":"2618615680","title":"CitiFirst CSL SFIs Dividend Estimated Amount-CTW","url":"https://stock-news.laohu8.com/highlight/detail?id=2618615680","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618615680?lang=en_us&edition=fundamental","pubTime":"2026-03-09 10:26","pubTimestamp":1773023202,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260309:nASX169Mry","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nASX7w6wtP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7508","CSL.AU","BK7501","BK7067"],"gpt_icon":0},{"id":"2617632533","title":"CSL Seqirus Wins Canada Pandemic Flu Vaccine Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2617632533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617632533?lang=en_us&edition=fundamental","pubTime":"2026-03-07 01:59","pubTimestamp":1772819991,"startTime":"0","endTime":"0","summary":"CSL Limited unit CSL Seqirus won a new contract with Canada’s Public Health Agency of Canada to support the country’s influenza pandemic preparedness plans. Under the agreement, CSL Seqirus will rapidly manufacture and deliver millions of doses of cell-based adjuvanted influenza vaccines if the World Health Organization declares an influenza pandemic, shifting from a prior egg-based vaccine arrangement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL3lQ6s7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","FUN","BK7508","BK4216","BK7501","CSL.AU","BK4590"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":198,"code":"91000000","status":"200"}]}}